BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jie Wang, Junqiao Jia, Ran Chen, Shanlong Ding, Qiang Xu, Ting Zhang, Xiangmei Chen, Shuang Liu, Fengmin Lu. RFX1 participates in doxorubicin-induced hepatitis B virus reactivationCancer Medicine 2018; 7(5): 2021 doi: 10.1002/cam4.1468
2
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic PatientsBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
3
Jason T. Blackard, Kenneth E. Sherman. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)Reviews in Medical Virology 2018; 28(4): e1984 doi: 10.1002/rmv.1984
4
Yu-tuan Wu, Xin Li, Zi-li Liu, Zhou Xu, Wei Dai, Ke Zhang, Jiu-song Wu, Bilal Arshad, Kai-nan Wu, Ling-quan Kong, Chiaho Shih. Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysisPLOS ONE 2017; 12(6): e0179680 doi: 10.1371/journal.pone.0179680
5
Catarina Meng, Carolina Belino, Luciano Pereira, Ana Pinho, Susana Sampaio, Isabel Tavares, Manuela Bustorff, António Sarmento, Manuel Pestana. Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: A single-center experienceNefrología 2018; 38(5): 545 doi: 10.1016/j.nefro.2018.02.004
6
Kyo Izumida, Atsushi Kaneko, Kazuya Takahashi, Shigeru Kusumoto, Tomoko Narita, Akiyoshi Takami, Shinsuke Iida, Katsumi Aoyagi, Yasuhito Tanaka. Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzerHepatology Research 2018; 48(13): 1081 doi: 10.1111/hepr.13229
7
Ioanna Aggeletopoulou, Christos Konstantakis, Spilios Manolakopoulos, Christos Triantos. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis CWorld Journal of Gastroenterology 2017; 23(24): 4317-4323 doi: 10.3748/wjg.v23.i24.4317
8
Eileen L. Yoon, Hyung Joon Yim. Updated Treatment of Chronic Hepatitis BThe Korean Journal of Medicine 2019; 94(3): 252 doi: 10.3904/kjm.2019.94.3.252
9
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for LymphomaAnnals of Hepatology 2017; 16(2): 198 doi: 10.5604/16652681.1231579
10
Martin Feuchtenberger, Arne Schäfer, Axel Philipp Nigg, Michael Rupert Kraus. Hepatitis B Serology in Patients with Rheumatic DiseasesThe Open Rheumatology Journal 2016; 10(1): 39 doi: 10.2174/1874312901610010039
11
Jacinta A. Holmes, Ming-Lung Yu, Raymond T. Chung. Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individualsExpert Opinion on Drug Safety 2017; 16(6): 651 doi: 10.1080/14740338.2017.1325869
12
Apostolos Koffas, Grace E Dolman, Patrick TF Kennedy. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for cliniciansClinical Medicine 2018; 18(3): 212 doi: 10.7861/clinmedicine.18-3-212
13
A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infectionJournal of Viral Hepatitis 2019;  doi: 10.1111/jvh.13101
14
Rashed Abdelaal, Beshoy Yanny, Mohamed El Kabany. HBV/HCV Coinfection in the Era of HCV-DAAsClinics in Liver Disease 2019; 23(3): 463 doi: 10.1016/j.cld.2019.04.003
15
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical ConsiderationsAmerican Journal of Clinical Dermatology 2019;  doi: 10.1007/s40257-019-00457-3
16
Hidetaka Matsuda, Katsushi Hiramatsu, Yu Akazawa, Takuto Nosaka, Yasushi Saito, Yoshihiko Ozaki, Ryoko Hayama, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Masahiro Ohtani, Tomoyuki Nemoto, Yukio Hida, Hideki Kimura, Yoshihiro Soya, Yasunari Nakamoto. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agentsJournal of Medical Virology 2018; 90(4): 712 doi: 10.1002/jmv.25011
17
J. Steuart Richards, Sharon Dowell, Mercedes Quinones. Comorbidity in Rheumatic Diseases2017; : 345 doi: 10.1007/978-3-319-59963-2_17
18
Aida Siyahian, Saad Ullah Malik, Adeela Mushtaq, Carol L. Howe, Aneela Majeed, Tirdad Zangeneh, Samar Iftikhar, Shahid Habib, Umar Zahid, Irbaz Bin Riaz, Zabih Warraich, Warda Faridi, Faiz Anwer. Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-AnalysisBiology of Blood and Marrow Transplantation 2018; 24(7): 1483 doi: 10.1016/j.bbmt.2018.02.027
19
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nagral, Amarender S. Puri, Padaki N. Rao, Neeraj Saraf, Vivek A. Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry T. Shenoy, Manav Wadhawan. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsJournal of Clinical and Experimental Hepatology 2018; 8(4): 403 doi: 10.1016/j.jceh.2018.06.010
20
Martina Vitrone, Domenico Iossa, Luca Rinaldi, Pia Clara Pafundi, Rosa Molaro, Antonio Parrella, Roberto Andini, Enrico Ragone, Ciro Maiello, Rosa Zampino, Emanuele Durante-Mangoni. Hepatitis B virus reactivation after heart transplant: Incidence and clinical impactJournal of Clinical Virology 2017; 96: 54 doi: 10.1016/j.jcv.2017.09.011
21
Marius Rademaker, Karen Agnew, Nicholas Anagnostou, Megan Andrews, Katherine Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Gillian Marshman, Diana Rubel, John Sullivan, Li‐Chuen Wong. Psoriasis and infection. A clinical practice narrativeAustralasian Journal of Dermatology 2019; 60(2): 91 doi: 10.1111/ajd.12895
22
Yu-Hung Wang, Ja-Der Liang, Wang-Huei Sheng, Feng-Ming Tien, Chien-Yuan Chen, Hwei-Fang Tien. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemiaLeukemia Research 2019; 81: 95 doi: 10.1016/j.leukres.2019.05.001
23
KASL clinical practice guidelines for management of chronic hepatitis BClinical and Molecular Hepatology 2019; 25(2): 93 doi: 10.3350/cmh.2019.1002
24
Alberto Enrico Maraolo, Ivan Gentile, Antonio Riccardo Buonomo, Biagio Pinchera, Guglielmo Borgia. Current evidence on the management of hepatitis B in pregnancyWorld Journal of Hepatology 2018; 10(9): 585-594 doi: 10.4254/wjh.v10.i9.585
25
María Buti, María L. Manzano, Rosa M. Morillas, Montserrat García-Retortillo, Leticia Martín, Martín Prieto, María L. Gutiérrez, Emilio Suárez, Mariano Gómez Rubio, Javier López, Pilar Castillo, Manuel Rodríguez, José M. Zozaya, Miguel A. Simón, Luis E. Morano, José L. Calleja, María Yébenes, Rafael Esteban, Vincent Wong. Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin studyPLOS ONE 2017; 12(9): e0184550 doi: 10.1371/journal.pone.0184550
26
Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapyBlood 2019; 133(2): 137 doi: 10.1182/blood-2018-04-848044
27
Catarina Meng, Carolina Belino, Luciano Pereira, Ana Pinho, Susana Sampaio, Isabel Tavares, Manuela Bustorff, António Sarmento, Manuel Pestana. Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: A single-center experienceNefrología (English Edition) 2018; 38(5): 545 doi: 10.1016/j.nefroe.2018.02.013
28
A. Marrone, N. Capoluongo, C. D'Amore, M. Pisaturo, M. Esposito, S. Guastafierro, I. Siniscalchi, M. Macera, A. Boemio, L. Onorato, L. Rinaldi, C. Minichini, L. E. Adinolfi, E. Sagnelli, L. Mastrullo, N. Coppola. Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapyJournal of Viral Hepatitis 2018; 25(2): 198 doi: 10.1111/jvh.12802
29
Eimear Kitt, Molly Hayes, Ana María Cárdenas, Abby M. Green. Interpretation and management of positive anti‐hepatitis B core antibody tests in immunocompromised pediatric patientsTransplant Infectious Disease 2019; 21(3): e13074 doi: 10.1111/tid.13074
30
Ahmad AlEnizi, Khaled AlSaeid, Adel Alawadhi, Eiman Hasan, Entesar H. Husain, Ahmad AlFadhli, Aqeel Ghanem, Fatemah Abutiban, Yaser Ali, Adeeba Al-Herz, Khuloud Mohammed, Waleed Alkandari, Ali Aldei, Hebah Alhajeri, Ahmad Dehrab, Sawsan Hayat. Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic DiseasesInternational Journal of Rheumatology 2018; 2018: 1 doi: 10.1155/2018/5217461
31
Beshoy T. Yanny, Nyan L. Latt, Sammy Saab, Steven Han, Gina Choi, Jason Kramer, Amandeep K. Sahota. Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus InfectionJournal of Clinical Gastroenterology 2018; 52(10): 908 doi: 10.1097/MCG.0000000000000986
32
Sarah R. Lieber, Michael W. Fried. Controversies in hepatitis C therapy: Reactivation of hepatitis B virusClinical Liver Disease 2017; 10(4): 87 doi: 10.1002/cld.665
33
Matthew Kelling, Lubomir Sokol, Samir Dalia. Hepatitis B Reactivation in the Treatment of Non-Hodgkin LymphomaCancer Control 2018; 25(1): 107327481876787 doi: 10.1177/1073274818767879